Department of Surgery, Institute of Molecular Medicine, Trinity Centre for Health Sciences, St James's Hospital and Trinity College, Dublin, Ireland.
Obes Rev. 2010 Dec;11(12):875-86. doi: 10.1111/j.1467-789X.2009.00700.x.
As the prevalence of obesity continues to rise in society, an increasing number of patients undergoing non-bariatric surgery will be obese. Obesity is known to increase morbidity and mortality in the general population and thus is perceived as a risk factor for adverse post-surgical outcomes. This association is not clear-cut, however, and there is a lack of consensus in the literature on the risk between obesity and specific complications, in particular relating to infection, wound healing, respiratory and venous thromboembolism. The paucity of studies, as well as a lack of consistency of definition of obesity, with an over-reliance on body mass index rather than body composition analysis, may underlie this confusion. Emerging concepts position central/visceral adipose tissue as potentially key to the pathogenesis of the comorbidities associated with obesity, thus this article reviews emerging research investigating the association between visceral obesity, the metabolic syndrome and resulting post-operative complications. It is hypothesized that the state of chronic inflammation and dysmetabolism observed in visceral obese patients negatively influences post-operative outcomes and represents a potential target for pharmaconutrition. The need for further research investigating the influence of visceral adiposity on immune function post surgery and its impact on post-operative morbidity and mortality is highlighted.
随着肥胖症在社会中的患病率不断上升,越来越多接受非减肥手术的患者将肥胖。肥胖症已知会增加普通人群的发病率和死亡率,因此被视为不良术后结果的危险因素。然而,这种关联并不明确,而且文献中对于肥胖症与特定并发症之间的风险存在缺乏共识,特别是与感染、伤口愈合、呼吸和静脉血栓栓塞有关的并发症。研究的缺乏,以及肥胖症定义的不一致,过度依赖体重指数而不是身体成分分析,可能是导致这种混淆的原因。新兴概念将中心/内脏脂肪组织定位为与肥胖相关的合并症发病机制的关键,因此本文综述了新兴研究调查内脏肥胖、代谢综合征与术后并发症之间的关联。据推测,在内脏肥胖患者中观察到的慢性炎症和代谢紊乱状态会对术后结果产生负面影响,并代表药物营养的潜在靶点。强调需要进一步研究调查内脏脂肪对手术后免疫功能的影响及其对术后发病率和死亡率的影响。